Cardiac Complications in Blood Cancers
It is crucial that oncology nurses monitor for cardiac complications in their patients with hematologic malignancies. And when one is discovered, they must act.
It is crucial that oncology nurses monitor for cardiac complications in their patients with hematologic malignancies. And when one is discovered, they must act.
In this episode of “The Vitals,” we spoke with Brenda Shelton, DNP, RN, APRN-CNS, CCRN, AOCN, a clinical nurse specialist at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. She discusses heart issues that can arise in patients with blood cancer, and what oncology nurses need to know. She gives a sneak peek of her upcoming presentation at the NCCN Virtual Annual Congress on Hematologic Malignancies and NCCN Virtual Nursing Forum, a free, online conference October 8-10.
FDA Grants Pirtobrutinib Accelerated Approval to Treat CLL/SLL in the Third Line
December 2nd 2023The FDA has approved the non-covalent BTK inhibitor, pirtobrutinib, to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have already undergone 2 lines of therapy.
